Article info

Download PDFPDF

Original article
IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer

Authors

  1. Correspondence to Dr Gregory B Lesinski, Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Building C, Room C3090, 1365 Clifton Rd. NE, Atlanta GA 30322, USA; gregory.b.lesinski{at}emory.edu
View Full Text

Citation

Mace TA, Shakya R, Pitarresi JR, et al
IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer

Publication history

  • Received February 2, 2016
  • Revised September 13, 2016
  • Accepted October 3, 2016
  • First published October 21, 2016.
Online issue publication 
January 08, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.